Maolate

   
Google
 
Web NewDrugInformation.com

Maolate


Drug - Maolate
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Chlorphenesin Carbamate
Multiple ingredients are in alphabetical order.

Strength - 400MG
The potency of the active ingredient(s), Chlorphenesin Carbamate. May repeat for multiple part products.

Applicant - PHARMACIA AND UPJOHN
The firm name holding legal responsibility for Maolate. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 014217
The FDA assigned number to Maolate. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Maolate. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Maolate was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Maolate. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Maolate is in. Format is RX, OTC, DISCN.

Applicant Full Name - Pharmacia And Upjohn Co
The full name of the firm holding legal responsibility for the new application of Maolate.

Maolate